Skip to main content
. 2022 Mar 10;12:823831. doi: 10.3389/fonc.2022.823831

Figure 5.

Figure 5

Efficiency of the MRG risk signature in prognostic prediction in AML from TCGA database. (A, B) Univariate and multivariate Cox analyses, which evaluated the risk signature’s independence in prognostic value in terms of overall survival in pediatric AML patients. (C) Nomograms for the probability of death at 1, 3, and 5 years. (D–F) The calibration curve of the nomograms. MRG, mitochondria-related gene; AML, acute myeloid leukemia; TCGA, The Cancer Genome Atlas. ***p < 0.001 in multivariate Cox analysis.